Use of cookies by
Norton Rose Fulbright
We use cookies to deliver our online services. Details and instructions on how to disable those cookies are set out at nortonrosefulbright.com/cookies-policy. By continuing to use this website you agree to our use of our cookies unless you have disabled them.
Norton Rose Fulbright names Oakes as new Austin Partner-in-Charge | United States | Global law firm | Norton Rose Fulbright

Norton Rose Fulbright names Oakes as new Austin Partner-in-Charge

June 21, 2018

Norton Rose Fulbright has appointed Mark Oakes as the Partner-in-Charge of its Austin office. The global law firm, which opened its Austin office 40 years ago, represents mature and growing companies, with a concentration on startups, particularly in the technology and innovation and life sciences and healthcare sectors.

Oakes, who joined Norton Rose Fulbright’s Austin office in 2007, said:

“I am excited for the opportunity to lead our fantastic team in Austin. Our focus on client service is paramount, and we’ll continue to develop innovative solutions for their legal and business needs.”

Oakes focuses his practice on commercial and securities litigation, including shareholder class action defense, derivative litigation, SEC enforcement matters, internal corporate investigations, M&A and corporate governance litigation, and complex contract and commercial litigation.

Oakes succeeds Stacey Martinez, whom the firm recently promoted to its Global Head of Life Sciences and Healthcare.

Daryl Lansdale, Norton Rose Fulbright’s US Managing Partner, said:

“Mark’s engaging personality and considerate approach make him an excellent choice to lead our dynamic 70-lawyer team in Austin. We value our unique culture, and we work hard to preserve it. I am confident that Mark will support his Austin colleagues in delivering a first-rate client experience.”

The lawyers in Norton Rose Fulbright’s Austin office focus on commercial litigation, real estate, tax, product liability and intellectual property, including patent prosecution.